Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs

A recent study reported that patients with interstitial lung disease (ILD) are at increased risk of death from coronavirus disease 2019 (COVID-19). However, there are no studies on the outcome of COVID-19 patients with preexisting ILD treated with corticosteroids or antiviral drugs. We extracted 26...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaya, Takafumi, Hagiwara, Eri, Baba, Tomohisa, Iwasawa, Tae, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995204/
https://www.ncbi.nlm.nih.gov/pubmed/35422381
http://dx.doi.org/10.1016/j.jiac.2022.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995204/
https://www.ncbi.nlm.nih.gov/pubmed/35422381
http://dx.doi.org/10.1016/j.jiac.2022.04.006

Ejemplares similares